VERTEX PHARMACEUTICALS INC / MA (VRTX)

Healthcare · Pharmaceutical Preparations

VERTEX PHARMACEUTICALS INC / MA (VRTX) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.

No institutional holder rows available yet for VRTX.

Recent insider transactions

DateInsiderTitleTypeValue
2026-07-02 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale $787.5K
2026-07-02 McKechnie Duncan EVP, Chief Commercial Officer Sale $799.8K
2026-07-01 Liu Joy EVP and Chief Legal Officer Sale $416.2K
2026-06-26 Bozic Carmen EVP and CMO Sale $287.6K
2026-06-18 Bozic Carmen EVP and CMO Sale $471.4K
2026-06-15 Bozic Carmen EVP and CMO Sale .83M
2026-06-05 Bozic Carmen EVP and CMO Sale $785.3K
2026-06-01 Liu Joy EVP and Chief Legal Officer Sale $364.2K

US equities research

Follow the money behind the market.

Public filings. Connected research. One workspace.

Click a source to open it in the workspace

InvestAtlant connects public filings, institutional activity, insider trades, congressional disclosures, and sector data to surface emerging market signals.

Signals

Where the market starts to move.

Detect emerging patterns, convergence, and divergence before they become obvious.

How it works

Three steps. From data to insight.

  1. Find

    Research stocks, investors, sectors, and politicians.

  2. Track

    Follow capital flows across sectors and filings.

  3. Detect

    Spot emerging alignment and divergence.

Fundamentals · Market context · Institutions · Insiders · Sectors · SEC filings

Open the research workspace.

Holdings from SEC 13F. Insider trades from Form 4. Congress from House and Senate PTRs. Real-time market prices via TradingView.